Francisco Partners IV, L.P.
CIK: 0001622902
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GoodRx Holdings, Inc.
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Aug 26, 2026GDRX
GoodRx Holdings, Inc.
Sale(S)Indirect213.4K shares at avg. $3.51$750K - Aug 26, 2026GDRX
GoodRx Holdings, Inc.
Sale(S)Indirect210.4K shares at avg. $3.51$739K - Aug 26, 2026GDRX
GoodRx Holdings, Inc.
Sale(S)Indirect439.3K shares at avg. $3.50$1.5M - Aug 26, 2026GDRX
GoodRx Holdings, Inc.
Sale(S)Indirect433.1K shares at avg. $3.50$1.5M - Aug 25, 2026GDRX
GoodRx Holdings, Inc.
Sale(S)Indirect64.1K shares at avg. $3.44$221K - Aug 25, 2026GDRX
GoodRx Holdings, Inc.
Sale(S)Indirect63.2K shares at avg. $3.44$218K - Aug 24, 2026GDRX
GoodRx Holdings, Inc.
Sale(S)Indirect71.3K shares at avg. $3.46$247K - Aug 24, 2026GDRX
GoodRx Holdings, Inc.
Sale(S)Indirect72.3K shares at avg. $3.46$250K - Aug 21, 2026GDRX
GoodRx Holdings, Inc.
Sale(S)Indirect138.3K shares at avg. $3.50$484K - Aug 21, 2026GDRX
GoodRx Holdings, Inc.
Sale(S)Indirect136.4K shares at avg. $3.50$477K - Aug 20, 2026GDRX
GoodRx Holdings, Inc.
Sale(S)Indirect233.4K shares at avg. $3.52$822K - Aug 20, 2026GDRX
GoodRx Holdings, Inc.
Sale(S)Indirect213.8K shares at avg. $3.52$753K - Aug 19, 2026GDRX
GoodRx Holdings, Inc.
Conversion(C)Indirect5M shares- - Aug 19, 2026GDRX
GoodRx Holdings, Inc.
Conversion(C)Indirect2.5M shares- - Aug 19, 2026GDRX
GoodRx Holdings, Inc.
Other(J)Indirect3.6M shares- - Aug 19, 2026GDRX
GoodRx Holdings, Inc.
Other(J)Indirect1.1M shares- - Aug 19, 2026GDRX
GoodRx Holdings, Inc.
Sale(S)Indirect237.7K shares at avg. $3.53$839K - Aug 19, 2026GDRX
GoodRx Holdings, Inc.
Sale(S)Indirect234.3K shares at avg. $3.53$827K - Mar 16, 2025GDRX
GoodRx Holdings, Inc.
Conversion(C)Indirect6.7M shares- - Mar 16, 2025GDRX
GoodRx Holdings, Inc.
Conversion(C)Indirect3.3M shares- - Mar 16, 2025GDRX
GoodRx Holdings, Inc.
Disposition(D)Indirect6.7M shares at avg. $4.20$28.0M - Mar 16, 2025GDRX
GoodRx Holdings, Inc.
Disposition(D)Indirect3.3M shares at avg. $4.20$14.0M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 26, 2026 | GDRX GoodRx Holdings, Inc. | Sale(S) | 213,401 | $3.51 | $749,571 | Indirect |
| Aug 26, 2026 | GDRX GoodRx Holdings, Inc. | Sale(S) | 210,378 | $3.51 | $738,953 | Indirect |
| Aug 26, 2026 | GDRX GoodRx Holdings, Inc. | Sale(S) | 439,310 | $3.50 | $1,537,585 | Indirect |
| Aug 26, 2026 | GDRX GoodRx Holdings, Inc. | Sale(S) | 433,088 | $3.50 | $1,515,808 | Indirect |
| Aug 25, 2026 | GDRX GoodRx Holdings, Inc. | Sale(S) | 64,090 | $3.44 | $220,784 | Indirect |
| Aug 25, 2026 | GDRX GoodRx Holdings, Inc. | Sale(S) | 63,183 | $3.44 | $217,659 | Indirect |
| Aug 24, 2026 | GDRX GoodRx Holdings, Inc. | Sale(S) | 71,285 | $3.46 | $246,789 | Indirect |
| Aug 24, 2026 | GDRX GoodRx Holdings, Inc. | Sale(S) | 72,309 | $3.46 | $250,334 | Indirect |
| Aug 21, 2026 | GDRX GoodRx Holdings, Inc. | Sale(S) | 138,338 | $3.50 | $483,740 | Indirect |
| Aug 21, 2026 | GDRX GoodRx Holdings, Inc. | Sale(S) | 136,379 | $3.50 | $476,890 | Indirect |
| Aug 20, 2026 | GDRX GoodRx Holdings, Inc. | Sale(S) | 233,415 | $3.52 | $821,738 | Indirect |
| Aug 20, 2026 | GDRX GoodRx Holdings, Inc. | Sale(S) | 213,844 | $3.52 | $752,838 | Indirect |
| Aug 19, 2026 | GDRX GoodRx Holdings, Inc. | Conversion(C) | 4,995,903 | - | $0 | Indirect |
| Aug 19, 2026 | GDRX GoodRx Holdings, Inc. | Conversion(C) | 2,504,097 | - | $0 | Indirect |
| Aug 19, 2026 | GDRX GoodRx Holdings, Inc. | Other(J) | 3,596,648 | - | $0 | Indirect |
| Aug 19, 2026 | GDRX GoodRx Holdings, Inc. | Other(J) | 1,142,357 | - | $0 | Indirect |
| Aug 19, 2026 | GDRX GoodRx Holdings, Inc. | Sale(S) | 237,671 | $3.53 | $838,955 | Indirect |
| Aug 19, 2026 | GDRX GoodRx Holdings, Inc. | Sale(S) | 234,304 | $3.53 | $827,070 | Indirect |
| Mar 16, 2025 | GDRX GoodRx Holdings, Inc. | Conversion(C) | 6,661,202 | - | - | Indirect |
| Mar 16, 2025 | GDRX GoodRx Holdings, Inc. | Conversion(C) | 3,338,798 | - | - | Indirect |
| Mar 16, 2025 | GDRX GoodRx Holdings, Inc. | Disposition(D) | 6,661,202 | $4.20 | $27,977,048 | Indirect |
| Mar 16, 2025 | GDRX GoodRx Holdings, Inc. | Disposition(D) | 3,338,798 | $4.20 | $14,022,952 | Indirect |
1-22 of 22 transactions
About FRANCISCO PARTNERS IV, L.P.
FRANCISCO PARTNERS IV, L.P. (SEC CIK 0001622902) files insider reports with the SEC as 10% Owner of GoodRx Holdings, Inc. (GDRX).
Signal8 holds 3 ownership filings by FRANCISCO PARTNERS IV, L.P., all Form 4s, filed between Mar 18, 2025 and Aug 26, 2026. Those filings report 22 transactions, from Mar 16, 2025 to Aug 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on FRANCISCO PARTNERS IV, L.P.'s filings is in SAN FRANCISCO, CA.
Recent filings by FRANCISCO PARTNERS IV, L.P.
- Aug 26, 2026: Open-market sales of GDRX shares (4 lines, Form 4, code S).
- Aug 25, 2026: Open-market sales of GDRX shares (2 lines, Form 4, code S).
- Aug 24, 2026: Open-market sales of GDRX shares (2 lines, Form 4, code S).
- Aug 21, 2026: Open-market sales of GDRX shares (2 lines, Form 4, code S).
- Aug 20, 2026: Open-market sales of GDRX shares (2 lines, Form 4, code S).
Other insiders filing for GoodRx Holdings, Inc. (GDRX)
- Hirsch Douglas Joseph, Director
- Fengler Justin
- Chan Thomas (TC), Chief Accounting Officer
- Barnes Wendy Lynn
- McGinnis Christopher A
- REY-GIRAUD AGNES, Director